György, Bence
Lööv, Camilla
Zaborowski, Mikołaj P.
Takeda, Shuko
Kleinstiver, Benjamin P.
Commins, Caitlin
Kastanenka, Ksenia
Mu, Dakai
Volak, Adrienn
Giedraitis, Vilmantas
Lannfelt, Lars
Maguire, Casey A.
Joung, J. Keith
Hyman, Bradley T.
Breakefield, Xandra O.
Ingelsson, Martin
Funding for this research was provided by:
Desmond and Ann Heathwood Massachusetts General Hospital Research Scholar
Edward R. and Anne G. Lefler Center Postdoctoral Fellow
Swedish Brain Foundation
Kosciuszko Foundation
Banting
Charles A. King Trust Postdoctoral Fellowships
The Marianne and Marcus Wallenberg Foundation (U19 CA179563)
NIH Common Fund
NIH
Maximizing Investigators’ Research Award (R35 118158)
NIH
NCRR (1S10RR028832-01)
This article is maintained by: Elsevier
Article Title: CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
Journal Title: Molecular Therapy - Nucleic Acids
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.omtn.2018.03.007
Content Type: article
Copyright: © 2018 The Author(s).